Telemedicine industry must embrace scrutiny to ensure quality

Research published earlier this week in JAMA Dermatology examining the accuracy and quality of services delivered by direct-to-consumer telemedicine companies caused quite a stir in the healthcare industry. Dan Bowman

In the study, researchers posed as dermatological patients for 62 clinical encounters. The authors found clinicians repeatedly missed major diagnoses, including syphilis, herpes and skin cancer, and did not ask relevant questions. Treatments sometimes were at odds with existing guidelines.

At a panel discussion Monday at the American Telemedicine Association's annual conference in Minneapolis, John Jesser, president of Anthem's LiveHealth Online, took issue with the use of "simulated patients," which he called "devious," according to both MedCity News and Politico Pro's Morning eHealth that in-person care can be subpar, as well.

>>Read the full commentary at FierceHealthIT